METROPOLITAN LIFE INSURANCE CO/NY - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2021$511,295
-35.9%
6,810
-0.8%
0.01%
-41.7%
Q3 2021$797,275
-17.6%
6,863
-6.3%
0.01%
-14.3%
Q1 2021$967,822
-26.9%
7,322
-4.3%
0.01%
-30.0%
Q4 2020$1,324,102
+182.8%
7,652
-3.1%
0.02%
+150.0%
Q2 2020$468,233
-77.2%
7,896
-71.3%
0.01%
-77.1%
Q3 2019$2,055,702
+38.6%
27,490
+17.2%
0.04%
+40.0%
Q2 2019$1,482,680
+31.3%
23,4490.0%0.02%
+25.0%
Q1 2019$1,129,53823,4490.02%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
StepStone Group LP 415,479$13,910,00019.11%
HARTLINE INVESTMENT CORP/ 405,066$13,562,0004.13%
APIS CAPITAL ADVISORS, LLC 81,100$2,715,0003.64%
Darsana Capital Partners LP 2,150,000$71,982,0003.01%
Rhenman & Partners Asset Management AB 545,000$18,247,0002.09%
Taylor Frigon Capital Management LLC 43,686$1,463,0001.29%
COURAGE CAPITAL MANAGEMENT LLC 40,000$1,339,0001.04%
Tygh Capital Management, Inc. 127,973$4,285,0000.90%
Granite Investment Partners, LLC 332,667$11,138,0000.81%
Steinberg Global Asset Management 135,394$4,533,0000.78%
View complete list of NOVOCURE LTD shareholders